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ABSTRACT 
Malaysia, due to its rapid growth and structured changes, has transformed into a 
prosperous, urban and industrialized economy since early '70s. Less than 5% households 
are considered poor compared to 50% in 1957, when the country achieved its 
independence. However, there are still substantial spatial individuals living in poverty, 
especially in rural areas. One of the sectors under food security in Malaysia, for protein 
sustainability, is increasing the amount of animal protein, so that they are readily accessible 
to the rural poor. Chicken meat has been identified as the cheapest source of animal 
protein. Poultry industry in Malaysia, largely propelled by the private sector, has 
significant contribution in supplying the protein needs of the population as reflected by 
the higher percentage share of the sector in the total livestock value. The annual 
production of eggs and meat are valued between RM 1.78 billion and RM 6.03 billion. 
Besides being a cheap source of protein, chicken has a special status due to its general 
acceptance among the Malaysian multi-racial and multi-ethnic population, since there is 
no religious restrictions associated with it. The rapid growth of the poultry industry is 
primarily due to the advances in poultry management, nutrition, genetics and better disease 
diagnosis and control. However, infectious diseases are still the major causes of losses in 
poultry industry and farmers depend mainly on imported vaccines, which are costly and 
sometimes may not be very effective. The need to provide constant source of cheap animal 
protein to the rural poor led our team to be involved in food security initiatives via 
disease control, by embarking on poultry vaccines development, targeting the control of 
diseases in village chickens, as well as commercial chickens. We focus on enhancing the 
health of poultry especially village chickens, for more than 20 years, by developing 
efficacious vaccines which are cheaper than the imported vaccines. One of the vaccines is 
for Newcastle disease, which is a very important disease in poultry, worldwide. The 
success of this vaccine, has led to an increase in number of village chickens being reared 
by rural farmers. Some farmers now rear large number of village chickens semi-
intensively. The development of this vaccine has also led to the establishment of the first 
and the only animal vaccine manufacturing company in the country, and it is now 
certified with Good Manufacturing Practice (GMP). Our research group has developed 
two other vaccines which are now sold in more than 8 countries. This paper highlights the 
stages of vaccine developments, from research, development, laboratory and field trials, 
up scaling and commercialization.  
 
